Phosphorus
New York
About Phosphorus
Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine by making it cost-effective, accessible, and actionable for our patients. Phosphorus’s suite of clinical-grade genomics tests use next-generation sequencing (NGS) and are available to patients through healthcare providers, hospitals, and directly to consumers through its website. The Phosphorus laboratory is CLIA and CAP certified and licensed for testing in all 50 states.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $18.0M
- Funding stage: M&A
- Last round: Seed (Jan 2023)
- Website: phosphorus.com
- Phone: +1 855 746 7423
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/phosphorus-141188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.